884 related articles for article (PubMed ID: 19308896)
1. Gene therapy for hemophilia: clinical trials and technical tribulations.
Viiala NO; Larsen SR; Rasko JE
Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical gene therapy for haemophilia.
Chuah MK; Collen D; Vandendriessche T
Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy strategies for hemophilia: benefits versus risks.
Petrus I; Chuah M; VandenDriessche T
J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer as an approach to treating hemophilia.
High KA
Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573
[TBL] [Abstract][Full Text] [Related]
5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for hemophilia.
Lynch CM
Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for hemophilia.
Ponder KP
Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
[TBL] [Abstract][Full Text] [Related]
8. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
Chuah M; Vandendriessche T
Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for hemophilia.
Chuah MK; Collen D; VandenDriessche T
J Gene Med; 2001; 3(1):3-20. PubMed ID: 11269333
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy in hemophilia: clinical trials update.
White GC
Thromb Haemost; 2001 Jul; 86(1):172-7. PubMed ID: 11487005
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for hemophilia].
Mimuro J; Sakata Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():646-54. PubMed ID: 16416868
[No Abstract] [Full Text] [Related]
13. Viral vector-mediated gene therapy for hemophilia B.
Eisensmith RC; Woo SL
Thromb Haemost; 1997 Jul; 78(1):24-30. PubMed ID: 9198122
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated gene therapy for hemophilia.
Couto LB; Pierce GF
Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
[TBL] [Abstract][Full Text] [Related]
15. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy progress and prospects: gene therapy for the hemophilias.
Walsh CE
Gene Ther; 2003 Jun; 10(12):999-1003. PubMed ID: 12776156
[TBL] [Abstract][Full Text] [Related]
17. Factoring nonviral gene therapy into a cure for hemophilia A.
Gabrovsky V; Calos MP
Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922
[TBL] [Abstract][Full Text] [Related]
18. AAV vectors for hemophilia B gene therapy.
Chao H; Walsh CE
Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
Chuah MK; Vandendriessche T
Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
[TBL] [Abstract][Full Text] [Related]
20. Nonviral gene therapy approaches to hemophilia.
Gómez-Vargas A; Hortelano G
Semin Thromb Hemost; 2004 Apr; 30(2):197-204. PubMed ID: 15118931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]